Feb 20 2026

Liangyou Rui, PhD (University of Michigan): “m6A-based Epitranscriptomicsin Health and Metabolic Disease”

February 20, 2026

11:00 AM - 12:00 PM

Location

Moss Auditorium, 1020 COMRB

Host: Yuwei Jiang, PhD

RNA modifications emerge as a critical mechanism to govern cell proliferation, differentiation, and function. METTL14 is an essential component of the N⁶-methyladenosine (m⁶A) transferase that deposits m⁶A methylation on RNA. YTHDC1 specifically binds m⁶A -methylated RNA to regulate RNA fate. We generated and characterized genetically modified mice with deletion of Mettl14 or Ythdc1 in adipocytes, hepatocytes, or neurons. Our results demonstrate that the METTL14/ m⁶A /YTHDC1 epitranscriptomic pathway shapes the activities of these cells and is indispensable for the maintenance of energy balance and metabolic homeostasis.

Contact

Edgar Solis

Date posted

Sep 12, 2025

Date updated

Feb 6, 2026

Speakers

Liangyou Rui, PhD